Literature DB >> 9392579

Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22.

M Baker1, J B Kwok, S Kucera, R Crook, M Farrer, H Houlden, A Isaacs, S Lincoln, L Onstead, J Hardy, L Wittenberg, P Dodd, S Webb, N Hayward, T Tannenberg, A Andreadis, M Hallupp, P Schofield, F Dark, M Hutton.   

Abstract

An Australian family with autosomal dominant presenile nonspecific dementia was recently described. The disease results in behavioral changes, usually disinhibition, followed by the onset of dementia accompanied occasionally by parkinsonism. Twenty-eight affected individuals were identified with an age of onset of 39 to 66 years (mean, 53 +/- 8.9 years). We mapped the disease locus to an approximately 26-cM region of chromosome 17q21-22 with a maximum two-point LOD score of 2.87. Affected individuals share a common haplotype between markers D17S783 and D17S808. This region of chromosome 17 contains the loci for several neurodegenerative diseases that lack distinctive pathological features, suggesting that these dementias, collectively referred to as frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), are caused by mutations in the same gene. The entire coding region of five genes, mapped to the FTDP-17 candidate region, were also sequenced. This analysis included the microtubule-associated protein tau that is the major component of the paired helical filaments observed in Alzheimer's disease. No pathogenic mutations were identified in either the tau gene or in any of the other genes analyzed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392579     DOI: 10.1002/ana.410420516

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.

Authors:  Zhihong Jiang; Hao Tang; Necat Havlioglu; Xiaochun Zhang; Stefan Stamm; Riqiang Yan; Jane Y Wu
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

2.  Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.

Authors:  William T Hu; Kelly Watts; Murray Grossman; Jonathan Glass; James J Lah; Chadwick Hales; Matthew Shelnutt; Vivianna Van Deerlin; John Q Trojanowski; Allan I Levey
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

Review 3.  Antibody Therapeutics Targeting Aβ and Tau.

Authors:  Gilbert Gallardo; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

4.  Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia.

Authors:  Casey Cook; Judy H Dunmore; Melissa E Murray; Kristyn Scheffel; Nawsheen Shukoor; Jimei Tong; Monica Castanedes-Casey; Virginia Phillips; Linda Rousseau; Michael S Penuliar; Aishe Kurti; Dennis W Dickson; Leonard Petrucelli; John D Fryer
Journal:  Neurobiol Aging       Date:  2013-12-26       Impact factor: 4.673

Review 5.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

Review 6.  The emerging link between O-GlcNAc and Alzheimer disease.

Authors:  Yanping Zhu; Xiaoyang Shan; Scott A Yuzwa; David J Vocadlo
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

7.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.

Authors:  Prudence M Stanford; William S Brooks; Erdahl T Teber; Marianne Hallupp; Catriona McLean; Glenda M Halliday; Ralph N Martins; John B J Kwok; Peter R Schofield
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

9.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

Authors:  L N Clark; P Poorkaj; Z Wszolek; D H Geschwind; Z S Nasreddine; B Miller; D Li; H Payami; F Awert; K Markopoulou; A Andreadis; I D'Souza; V M Lee; L Reed; J Q Trojanowski; V Zhukareva; T Bird; G Schellenberg; K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 10.  New age of neuroproteomics in Alzheimer's disease research.

Authors:  Branislav Kovacech; Norbert Zilka; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-02-19       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.